January 26, 2011: Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent Study Is the First Randomized Multi-Center Bifurcation Trial in the United States Download PDF
Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent
Dateline City: DURHAM, N.C. Study Is the First Randomized Multi-Center Bifurcation Trial in the United States DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first U.S. patient has been enrolled in the pivotal trial to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery …
Tryton Announces Enrollment of First Patient in U.S. Pivotal Study of Side Branch Stent Study to Enroll 704 Patients At Up To 75 Centers in North America and Europe
December 20, 2010: Tryton Announces Enrollment of First Patient in U.S. Pivotal Study of Side Branch Stent Study to Enroll 704 Patients At Up To 75 Centers in North America and Europe Download PDF
Tryton Announces Enrollment of First Patient in U.S. Pivotal Study of Side Branch Stent
Dateline City: DURHAM, N.C. Study to Enroll 704 Patients At Up To 75 Centers in North America and Europe Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in the pivotal trial to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery …
Tryton Announces Investigational Device Exemption Conditional Approval from FDA to Conduct U.S. Pivotal Study of Side Branch Stent Study to Enroll 700 Patients At Up To 75 Centers in North America and Europe
December 2, 2010: Tryton Announces Investigational Device Exemption Conditional Approval from FDA to Conduct U.S. Pivotal Study of Side Branch Stent Study to Enroll 700 Patients At Up To 75 Centers in North America and Europe Download PDF
Tryton Announces Investigational Device Exemption Conditional Approval from FDA to Conduct U.S. Pivotal Study of Side Branch Stent
Dateline City: DURHAM, N.C. Study to Enroll 700 Patients At Up To 75 Centers in North America and Europe DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced U.S. Food and Drug Administration (FDA) conditional approval for an Investigational Device Exemption (IDE) application to initiate the pivotal trial to evaluate the …
Clinical Study Featuring Tryton Stent Wins Best Abstract Award at Italian Society of Interventional Cardiology National Congress (GISE) in Genoa, Italy Live Case Transmission During Conference Demonstrates Ease-of-Use of Tryton Stent System
November 2, 2010: Clinical Study Featuring Tryton Stent Wins Best Abstract Award at Italian Society of Interventional Cardiology National Congress (GISE) in Genoa, Italy Live Case Transmission During Conference Demonstrates Ease-of-Use of Tryton Stent System Download PDF
Clinical Study Featuring Tryton Stent Wins Best Abstract Award at Italian Society of Interventional Cardiology National Congress (GISE) in Genoa, Italy
Dateline City: DURHAM, N.C. Live Case Transmission During Conference Demonstrates Ease-of-Use of Tryton Stent System DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that an abstract reporting results from the company’s Tryton stent system was recognized as the best presented at the Italian Society of Interventional Cardiology National Congress (GISE) …
First patient enrolled in E-Tryton Italy study
First patient enrolled in E-Tryton Italy study Medical Device Daily October 13, 2010 Download PDF
Tryton Announces First Patient Enrollment in E-Tryton Italy Registry of the Tryton Side Branch Stent System Study To Assess Real-Life Clinical Results in 300 Patients With Bifurcation Disease in Italy
October 12, 2010: Tryton Announces First Patient Enrollment in E-Tryton Italy Registry of the Tryton Side Branch Stent System Study To Assess Real-Life Clinical Results in 300 Patients With Bifurcation Disease in Italy Download PDF